GERRESHEIMER AG (GXI.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:GXI - DE000A0LD6E6 - Common Stock
25.86 EUR
-0.4 (-1.52%)
GXI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 20 industry peers in the Life Sciences Tools & Services industry. Both the profitability and financial health of GXI have multiple concerns. GXI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year GXI was profitable.
GXI had a positive operating cash flow in the past year.
Each year in the past 5 years GXI has been profitable.
Each year in the past 5 years GXI had a positive operating cash flow.
1.2 Ratios
GXI's Return On Assets of 0.50% is on the low side compared to the rest of the industry. GXI is outperformed by 89.47% of its industry peers.
Looking at the Return On Equity, with a value of 1.67%, GXI is doing worse than 84.21% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.79%, GXI is doing worse than 89.47% of the companies in the same industry.
GXI had an Average Return On Invested Capital over the past 3 years of 6.14%. This is below the industry average of 9.25%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROIC | 2.79% |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
1.3 Margins
GXI has a Profit Margin of 1.04%. This is amonst the worse of the industry: GXI underperforms 89.47% of its industry peers.
In the last couple of years the Profit Margin of GXI has remained more or less at the same level.
GXI has a worse Operating Margin (5.99%) than 89.47% of its industry peers.
In the last couple of years the Operating Margin of GXI has grown nicely.
GXI's Gross Margin of 26.89% is on the low side compared to the rest of the industry. GXI is outperformed by 78.95% of its industry peers.
In the last couple of years the Gross Margin of GXI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% |
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GXI is destroying value.
The number of shares outstanding for GXI remains at a similar level compared to 1 year ago.
The number of shares outstanding for GXI has been increased compared to 5 years ago.
GXI has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.95, we must say that GXI is in the distress zone and has some risk of bankruptcy.
GXI has a worse Altman-Z score (0.95) than 78.95% of its industry peers.
GXI has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.22, GXI is not doing good in the industry: 73.68% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.95 |
ROIC/WACC0.35
WACC8.05%
2.3 Liquidity
A Current Ratio of 0.98 indicates that GXI may have some problems paying its short term obligations.
GXI has a Current ratio of 0.98. This is in the lower half of the industry: GXI underperforms 78.95% of its industry peers.
GXI has a Quick Ratio of 0.98. This is a bad value and indicates that GXI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of GXI (0.52) is worse than 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 |
3. Growth
3.1 Past
The earnings per share for GXI have decreased strongly by -19.08% in the last year.
Measured over the past years, GXI shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.23% on average per year.
GXI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.83%.
Measured over the past years, GXI shows a small growth in Revenue. The Revenue has been growing by 7.90% on average per year.
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
3.2 Future
Based on estimates for the next years, GXI will show a small growth in Earnings Per Share. The EPS will grow by 6.02% on average per year.
The Revenue is expected to grow by 7.40% on average over the next years.
EPS Next Y-33.84%
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
EPS Next 5Y6.02%
Revenue Next Year13.08%
Revenue Next 2Y8.77%
Revenue Next 3Y7.87%
Revenue Next 5Y7.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
GXI is valuated cheaply with a Price/Earnings ratio of 7.01.
GXI's Price/Earnings ratio is rather cheap when compared to the industry. GXI is cheaper than 100.00% of the companies in the same industry.
GXI is valuated cheaply when we compare the Price/Earnings ratio to 26.49, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 7.69, the valuation of GXI can be described as very cheap.
Based on the Price/Forward Earnings ratio, GXI is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, GXI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.01 | ||
| Fwd PE | 7.69 |
4.2 Price Multiples
94.74% of the companies in the same industry are more expensive than GXI, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 7.36 |
4.3 Compensation for Growth
A cheap valuation may be justified as GXI's earnings are expected to decrease with -4.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
5. Dividend
5.1 Amount
With a yearly dividend of 0.15%, GXI is not a good candidate for dividend investing.
In the last 3 months the price of GXI has falen by -37.29%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 0.71, GXI is paying slightly less dividend.
With a Dividend Yield of 0.15, GXI pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.15% |
5.2 History
The dividend of GXI has a limited annual growth rate of 0.94%.
Dividend Growth(5Y)0.94%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
GXI pays out 10.12% of its income as dividend. This is a sustainable payout ratio.
The dividend of GXI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP10.12%
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
FRA:GXI (12/5/2025, 7:00:00 PM)
25.86
-0.4 (-1.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.82%
Inst Owner ChangeN/A
Ins Owners4.92%
Ins Owner ChangeN/A
Market Cap893.20M
Revenue(TTM)2.25B
Net Income(TTM)23.35M
Analysts65.22
Price Target38.74 (49.81%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.15% |
Yearly Dividend1.32
Dividend Growth(5Y)0.94%
DP10.12%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.39%
Min EPS beat(2)-6.69%
Max EPS beat(2)1.92%
EPS beat(4)3
Avg EPS beat(4)7.96%
Min EPS beat(4)-6.69%
Max EPS beat(4)18.84%
EPS beat(8)5
Avg EPS beat(8)4.68%
EPS beat(12)8
Avg EPS beat(12)3.75%
EPS beat(16)9
Avg EPS beat(16)2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.48%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)-0.85%
Revenue beat(4)0
Avg Revenue beat(4)-1.32%
Min Revenue beat(4)-2.11%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.27%
PT rev (1m)-3.39%
PT rev (3m)-41.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.91%
EPS NY rev (1m)-1.1%
EPS NY rev (3m)-19.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.83%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-4.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.01 | ||
| Fwd PE | 7.69 | ||
| P/S | 0.4 | ||
| P/FCF | N/A | ||
| P/OCF | 3.52 | ||
| P/B | 0.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.36 |
EPS(TTM)3.69
EY14.27%
EPS(NY)3.36
Fwd EY13%
FCF(TTM)-2.51
FCFYN/A
OCF(TTM)7.34
OCFY28.39%
SpS65.15
BVpS40.59
TBVpS-8.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.5% | ||
| ROE | 1.67% | ||
| ROCE | 3.76% | ||
| ROIC | 2.79% | ||
| ROICexc | 2.93% | ||
| ROICexgc | 5.89% | ||
| OM | 5.99% | ||
| PM (TTM) | 1.04% | ||
| GM | 26.89% | ||
| FCFM | N/A |
ROA(3y)3.04%
ROA(5y)3.09%
ROE(3y)7.67%
ROE(5y)8.3%
ROIC(3y)6.14%
ROIC(5y)6.08%
ROICexc(3y)6.5%
ROICexc(5y)6.42%
ROICexgc(3y)14.47%
ROICexgc(5y)16.32%
ROCE(3y)8.29%
ROCE(5y)8.2%
ROICexgc growth 3Y-17.1%
ROICexgc growth 5Y-18.13%
ROICexc growth 3Y-1.3%
ROICexc growth 5Y1.06%
OM growth 3Y-0.21%
OM growth 5Y2.69%
PM growth 3Y-1.23%
PM growth 5Y-1.47%
GM growth 3Y0.37%
GM growth 5Y1.38%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.22 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.4 | ||
| Cap/Depr | 134.54% | ||
| Cap/Sales | 15.12% | ||
| Interest Coverage | 1.65 | ||
| Cash Conversion | 65.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.52 | ||
| Altman-Z | 0.95 |
F-Score4
WACC8.05%
ROIC/WACC0.35
Cap/Depr(3y)167.14%
Cap/Depr(5y)152.09%
Cap/Sales(3y)15.92%
Cap/Sales(5y)14.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.08%
EPS 3Y4.26%
EPS 5Y-8.23%
EPS Q2Q%-39.66%
EPS Next Y-33.84%
EPS Next 2Y-15.26%
EPS Next 3Y-4.47%
EPS Next 5Y6.02%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.9%
Sales Q2Q%12.47%
Revenue Next Year13.08%
Revenue Next 2Y8.77%
Revenue Next 3Y7.87%
Revenue Next 5Y7.4%
EBIT growth 1Y-34.26%
EBIT growth 3Y10.54%
EBIT growth 5Y10.8%
EBIT Next Year91.04%
EBIT Next 3Y32.46%
EBIT Next 5Y21.19%
FCF growth 1Y-1073.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.63%
OCF growth 3Y4.26%
OCF growth 5Y4.49%
GERRESHEIMER AG / GXI.DE FAQ
What is the ChartMill fundamental rating of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to GXI.DE.
What is the valuation status of GERRESHEIMER AG (GXI.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to GERRESHEIMER AG (GXI.DE). This can be considered as Fairly Valued.
How profitable is GERRESHEIMER AG (GXI.DE) stock?
GERRESHEIMER AG (GXI.DE) has a profitability rating of 3 / 10.
How financially healthy is GERRESHEIMER AG?
The financial health rating of GERRESHEIMER AG (GXI.DE) is 0 / 10.
What is the expected EPS growth for GERRESHEIMER AG (GXI.DE) stock?
The Earnings per Share (EPS) of GERRESHEIMER AG (GXI.DE) is expected to decline by -33.84% in the next year.